Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-11-03
DOI
https://doi.org/10.7326/annals-25-01724
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes

Wajd Alkabbani, Elaine W Yu, Elisabetta Patorno, Salvatore Crisafulli et al.
1 citations
Annals of Internal Medicine
Diabetes Treatment and Management
1.29
article

Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes

Wajd Alkabbani, Elaine W Yu, Elisabetta Patorno, Salvatore Crisafulli, Gianluca Trifirò, Deborah J. Wexler, Ali Tavakkoli, Katsiaryna Bykov, Julie M. Paik, Phyo Than Htoo, Robert J. Glynn
article en
1 citations

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 179(1)
University of Verona (IT), Brigham and Women's Hospital (US), Massachusetts General Hospital (US)
Openalex Percentile: Top 14%
Diabetes Treatment and Management
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.